annual CFO:
$455.20M+$80.30M(+21.42%)Summary
- As of today (May 31, 2025), BIO annual cash flow from operations is $455.20 million, with the most recent change of +$80.30 million (+21.42%) on December 31, 2024.
- During the last 3 years, BIO annual CFO has fallen by -$214.26 million (-32.01%).
- BIO annual CFO is now -32.01% below its all-time high of $669.46 million, reached on December 31, 2021.
Performance
BIO Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$129.90M+$5.75M(+4.63%)Summary
- As of today (May 31, 2025), BIO quarterly cash flow from operations is $129.90 million, with the most recent change of +$5.75 million (+4.63%) on March 31, 2025.
- Over the past year, BIO quarterly CFO has increased by +$60.10 million (+86.10%).
- BIO quarterly CFO is now -55.87% below its all-time high of $294.38 million, reached on December 31, 2020.
Performance
BIO quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$515.30M+$60.10M(+13.20%)Summary
- As of today (May 31, 2025), BIO TTM cash flow from operations is $515.30 million, with the most recent change of +$60.10 million (+13.20%) on March 31, 2025.
- Over the past year, BIO TTM CFO has increased by +$168.72 million (+48.68%).
- BIO TTM CFO is now -35.02% below its all-time high of $792.98 million, reached on September 30, 2021.
Performance
BIO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BIO Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.4% | +86.1% | +48.7% |
| 3 y3 years | -32.0% | +157.3% | -15.0% |
| 5 y5 years | -0.6% | +106.8% | +7.9% |
BIO Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -32.0% | +134.2% | -20.6% | +1078.0% | -15.0% | +165.1% |
| 5 y | 5-year | -32.0% | +134.2% | -55.9% | +1078.0% | -35.0% | +165.1% |
| alltime | all time | -32.0% | >+9999.0% | -55.9% | +331.1% | -35.0% | +5955.7% |
BIO Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $129.90M(+4.6%) | $515.30M(+13.2%) |
| Dec 2024 | $455.20M(+21.4%) | $124.15M(-24.1%) | $455.20M(+10.5%) |
| Sep 2024 | - | $163.61M(+67.6%) | $412.05M(+19.0%) |
| Jun 2024 | - | $97.64M(+39.9%) | $346.15M(-0.1%) |
| Mar 2024 | - | $69.80M(-13.8%) | $346.58M(-7.6%) |
| Dec 2023 | $374.90M(+92.8%) | $81.00M(-17.1%) | $374.90M(+0.4%) |
| Sep 2023 | - | $97.71M(-0.4%) | $373.51M(+30.2%) |
| Jun 2023 | - | $98.07M(-0.1%) | $286.82M(+18.5%) |
| Mar 2023 | - | $98.12M(+23.2%) | $242.03M(+24.5%) |
| Dec 2022 | $194.40M(-71.0%) | $79.61M(+622.0%) | $194.40M(-31.9%) |
| Sep 2022 | - | $11.03M(-79.3%) | $285.66M(-43.4%) |
| Jun 2022 | - | $53.27M(+5.5%) | $504.99M(-16.7%) |
| Mar 2022 | - | $50.49M(-70.4%) | $606.35M(-9.4%) |
| Dec 2021 | $669.46M(+14.4%) | $170.87M(-25.8%) | $669.46M(-15.6%) |
| Sep 2021 | - | $230.36M(+49.0%) | $792.98M(+13.6%) |
| Jun 2021 | - | $154.62M(+36.1%) | $698.28M(+9.8%) |
| Mar 2021 | - | $113.61M(-61.4%) | $635.77M(+8.7%) |
| Dec 2020 | $584.97M(+27.8%) | $294.38M(+117.0%) | $584.97M(+29.9%) |
| Sep 2020 | - | $135.66M(+47.3%) | $450.40M(+8.7%) |
| Jun 2020 | - | $92.12M(+46.7%) | $414.48M(-13.2%) |
| Mar 2020 | - | $62.81M(-60.7%) | $477.76M(+4.3%) |
| Dec 2019 | $457.90M(+60.4%) | $159.80M(+60.2%) | $457.90M(+13.6%) |
| Sep 2019 | - | $99.75M(-35.8%) | $403.10M(+10.2%) |
| Jun 2019 | - | $155.40M(+261.9%) | $365.63M(+26.9%) |
| Mar 2019 | - | $42.94M(-59.1%) | $288.09M(+0.9%) |
| Dec 2018 | $285.49M(+174.2%) | $105.01M(+68.6%) | $285.49M(+14.3%) |
| Sep 2018 | - | $62.28M(-20.0%) | $249.85M(+15.6%) |
| Jun 2018 | - | $77.86M(+93.0%) | $216.05M(+7.7%) |
| Mar 2018 | - | $40.35M(-41.8%) | $200.69M(+92.7%) |
| Dec 2017 | $104.14M(-51.8%) | $69.36M(+143.6%) | $104.14M(-19.6%) |
| Sep 2017 | - | $28.48M(-54.4%) | $129.52M(-15.2%) |
| Jun 2017 | - | $62.50M(-211.2%) | $152.66M(-8.8%) |
| Mar 2017 | - | -$56.20M(-159.3%) | $167.31M(-22.6%) |
| Dec 2016 | $216.07M(+16.0%) | $94.75M(+83.6%) | $216.07M(+37.4%) |
| Sep 2016 | - | $51.61M(-33.1%) | $157.27M(-16.3%) |
| Jun 2016 | - | $77.16M(-1135.9%) | $187.94M(+25.9%) |
| Mar 2016 | - | -$7.45M(-120.7%) | $149.32M(-19.8%) |
| Dec 2015 | $186.21M(-31.9%) | $35.95M(-56.3%) | $186.21M(-2.2%) |
| Sep 2015 | - | $82.28M(+113.5%) | $190.47M(-4.2%) |
| Jun 2015 | - | $38.53M(+30.9%) | $198.85M(-16.2%) |
| Mar 2015 | - | $29.45M(-26.8%) | $237.19M(-13.2%) |
| Dec 2014 | $273.31M(+61.6%) | $40.22M(-55.6%) | $273.31M(-10.0%) |
| Sep 2014 | - | $90.65M(+17.9%) | $303.65M(+13.4%) |
| Jun 2014 | - | $76.87M(+17.2%) | $267.82M(+27.1%) |
| Mar 2014 | - | $65.57M(-7.1%) | $210.69M(+24.6%) |
| Dec 2013 | $169.14M(-36.5%) | $70.55M(+28.7%) | $169.14M(-8.5%) |
| Sep 2013 | - | $54.83M(+177.8%) | $184.82M(-8.2%) |
| Jun 2013 | - | $19.74M(-17.8%) | $201.33M(-21.1%) |
| Mar 2013 | - | $24.02M(-72.1%) | $255.24M(-4.2%) |
| Dec 2012 | $266.48M(+1.4%) | $86.24M(+20.9%) | $266.48M(+1.8%) |
| Sep 2012 | - | $71.34M(-3.1%) | $261.74M(+8.4%) |
| Jun 2012 | - | $73.64M(+108.9%) | $241.56M(-13.2%) |
| Mar 2012 | - | $35.26M(-56.7%) | $278.21M(+5.9%) |
| Dec 2011 | $262.74M(+16.3%) | $81.50M(+59.3%) | $262.74M(-6.7%) |
| Sep 2011 | - | $51.16M(-53.6%) | $281.63M(-5.3%) |
| Jun 2011 | - | $110.30M(+457.6%) | $297.33M(+33.1%) |
| Mar 2011 | - | $19.78M(-80.3%) | $223.42M(-1.1%) |
| Dec 2010 | $225.91M(-30.5%) | $100.39M(+50.1%) | $225.91M(-6.4%) |
| Sep 2010 | - | $66.87M(+83.8%) | $241.24M(-11.3%) |
| Jun 2010 | - | $36.39M(+63.4%) | $271.87M(-20.3%) |
| Mar 2010 | - | $22.27M(-80.8%) | $340.97M(+4.9%) |
| Dec 2009 | $325.07M(+69.9%) | $115.72M(+18.7%) | $325.07M(+13.0%) |
| Sep 2009 | - | $97.49M(-7.6%) | $287.69M(+21.7%) |
| Jun 2009 | - | $105.49M(+1555.8%) | $236.32M(+18.2%) |
| Mar 2009 | - | $6.37M(-91.9%) | $199.92M(+4.5%) |
| Dec 2008 | $191.37M(-0.1%) | $78.34M(+69.9%) | $191.37M(-11.5%) |
| Sep 2008 | - | $46.12M(-33.2%) | $216.18M(-3.9%) |
| Jun 2008 | - | $69.09M(-3273.5%) | $225.06M(+11.4%) |
| Mar 2008 | - | -$2.18M(-102.1%) | $202.04M(+5.5%) |
| Dec 2007 | $191.58M | $103.15M(+87.6%) | $191.58M(+33.7%) |
| Sep 2007 | - | $55.00M(+19.4%) | $143.29M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | $46.07M(-464.5%) | $140.17M(-5.1%) |
| Mar 2007 | - | -$12.64M(-123.0%) | $147.66M(+24.9%) |
| Dec 2006 | $118.23M(+9.2%) | $54.86M(+5.8%) | $118.23M(+4.9%) |
| Sep 2006 | - | $51.87M(-3.2%) | $112.76M(+22.6%) |
| Jun 2006 | - | $53.56M(-227.3%) | $91.96M(+122.5%) |
| Mar 2006 | - | -$42.07M(-185.2%) | $41.33M(-61.8%) |
| Dec 2005 | $108.28M(-12.0%) | $49.39M(+59.0%) | $108.28M(-1.5%) |
| Sep 2005 | - | $31.07M(+958.7%) | $109.92M(+6.3%) |
| Jun 2005 | - | $2.94M(-88.2%) | $103.37M(-14.3%) |
| Mar 2005 | - | $24.88M(-51.2%) | $120.67M(-2.0%) |
| Dec 2004 | $123.09M(-3.6%) | $51.03M(+108.1%) | $123.09M(+11.8%) |
| Sep 2004 | - | $24.52M(+21.2%) | $110.14M(-14.4%) |
| Jun 2004 | - | $20.24M(-25.9%) | $128.59M(-3.5%) |
| Mar 2004 | - | $27.31M(-28.3%) | $133.23M(+4.4%) |
| Dec 2003 | $127.64M(+20.7%) | $38.08M(-11.4%) | $127.64M(+2.0%) |
| Sep 2003 | - | $42.97M(+72.8%) | $125.17M(+9.4%) |
| Jun 2003 | - | $24.87M(+14.5%) | $114.38M(+4.6%) |
| Mar 2003 | - | $21.72M(-39.0%) | $109.34M(+3.4%) |
| Dec 2002 | $105.76M(+6.3%) | $35.61M(+10.7%) | $105.76M(-4.3%) |
| Sep 2002 | - | $32.18M(+62.2%) | $110.56M(+10.0%) |
| Jun 2002 | - | $19.83M(+9.4%) | $100.47M(-13.0%) |
| Mar 2002 | - | $18.14M(-55.1%) | $115.42M(+16.0%) |
| Dec 2001 | $99.50M(+310.3%) | $40.41M(+83.0%) | $99.50M(+53.2%) |
| Sep 2001 | - | $22.08M(-36.5%) | $64.97M(+31.8%) |
| Jun 2001 | - | $34.78M(+1470.4%) | $49.28M(+52.6%) |
| Mar 2001 | - | $2.21M(-62.3%) | $32.28M(+33.1%) |
| Dec 2000 | $24.25M(-46.1%) | $5.88M(-8.1%) | $24.25M(-40.1%) |
| Sep 2000 | - | $6.40M(-64.0%) | $40.47M(-7.8%) |
| Jun 2000 | - | $17.79M(-405.5%) | $43.87M(+16.1%) |
| Mar 2000 | - | -$5.82M(-126.3%) | $37.78M(-16.0%) |
| Dec 1999 | $45.00M(+64.8%) | $22.10M(+125.5%) | $45.00M(+31.2%) |
| Sep 1999 | - | $9.80M(-16.2%) | $34.30M(+3.9%) |
| Jun 1999 | - | $11.70M(+735.7%) | $33.00M(+14.6%) |
| Mar 1999 | - | $1.40M(-87.7%) | $28.80M(+5.5%) |
| Dec 1998 | $27.30M(+29.4%) | $11.40M(+34.1%) | $27.30M(+33.2%) |
| Sep 1998 | - | $8.50M(+13.3%) | $20.50M(-6.4%) |
| Jun 1998 | - | $7.50M(-7600.0%) | $21.90M(+0.9%) |
| Mar 1998 | - | -$100.00K(-102.2%) | $21.70M(+2.8%) |
| Dec 1997 | $21.10M(-36.4%) | $4.60M(-53.5%) | $21.10M(-15.6%) |
| Sep 1997 | - | $9.90M(+35.6%) | $25.00M(+51.5%) |
| Jun 1997 | - | $7.30M(-1142.9%) | $16.50M(-31.5%) |
| Mar 1997 | - | -$700.00K(-108.2%) | $24.10M(-27.4%) |
| Dec 1996 | $33.20M(-13.1%) | $8.50M(+507.1%) | $33.20M(-16.2%) |
| Sep 1996 | - | $1.40M(-90.6%) | $39.60M(-8.8%) |
| Jun 1996 | - | $14.90M(+77.4%) | $43.40M(+13.9%) |
| Mar 1996 | - | $8.40M(-43.6%) | $38.10M(-0.3%) |
| Dec 1995 | $38.20M(-20.9%) | $14.90M(+186.5%) | $38.20M(+9.8%) |
| Sep 1995 | - | $5.20M(-45.8%) | $34.80M(-6.2%) |
| Jun 1995 | - | $9.60M(+12.9%) | $37.10M(-11.2%) |
| Mar 1995 | - | $8.50M(-26.1%) | $41.80M(-13.5%) |
| Dec 1994 | $48.30M(+114.7%) | $11.50M(+53.3%) | $48.30M(-15.9%) |
| Sep 1994 | - | $7.50M(-47.6%) | $57.40M(+5.1%) |
| Jun 1994 | - | $14.30M(-4.7%) | $54.60M(+37.9%) |
| Mar 1994 | - | $15.00M(-27.2%) | $39.60M(+76.0%) |
| Dec 1993 | $22.50M(+462.5%) | $20.60M(+338.3%) | $22.50M(-355.7%) |
| Sep 1993 | - | $4.70M(-771.4%) | -$8.80M(-269.2%) |
| Jun 1993 | - | -$700.00K(-66.7%) | $5.20M(+23.8%) |
| Mar 1993 | - | -$2.10M(-80.4%) | $4.20M(+5.0%) |
| Dec 1992 | $4.00M(-2.4%) | -$10.70M(-157.2%) | $4.00M(-81.6%) |
| Sep 1992 | - | $18.70M(-1200.0%) | $21.70M(+933.3%) |
| Jun 1992 | - | -$1.70M(-26.1%) | $2.10M(-63.2%) |
| Mar 1992 | - | -$2.30M(-132.9%) | $5.70M(+39.0%) |
| Dec 1991 | $4.10M(-66.1%) | $7.00M(-877.8%) | $4.10M(-1466.7%) |
| Sep 1991 | - | -$900.00K(-147.4%) | -$300.00K(-105.9%) |
| Jun 1991 | - | $1.90M(-148.7%) | $5.10M(+34.2%) |
| Mar 1991 | - | -$3.90M(-250.0%) | $3.80M(-68.6%) |
| Dec 1990 | $12.10M(+23.5%) | $2.60M(-42.2%) | $12.10M(+27.4%) |
| Sep 1990 | - | $4.50M(+650.0%) | $9.50M(+90.0%) |
| Jun 1990 | - | $600.00K(-86.4%) | $5.00M(+13.6%) |
| Mar 1990 | - | $4.40M | $4.40M |
| Dec 1989 | $9.80M | - | - |
FAQ
- What is Bio-Rad Laboratories annual cash flow from operations?
- What is the all time high annual CFO for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual CFO year-on-year change?
- What is Bio-Rad Laboratories quarterly cash flow from operations?
- What is the all time high quarterly CFO for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly CFO year-on-year change?
- What is Bio-Rad Laboratories TTM cash flow from operations?
- What is the all time high TTM CFO for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories TTM CFO year-on-year change?
What is Bio-Rad Laboratories annual cash flow from operations?
The current annual CFO of BIO is $455.20M
What is the all time high annual CFO for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual cash flow from operations is $669.46M
What is Bio-Rad Laboratories annual CFO year-on-year change?
Over the past year, BIO annual cash flow from operations has changed by +$80.30M (+21.42%)
What is Bio-Rad Laboratories quarterly cash flow from operations?
The current quarterly CFO of BIO is $129.90M
What is the all time high quarterly CFO for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly cash flow from operations is $294.38M
What is Bio-Rad Laboratories quarterly CFO year-on-year change?
Over the past year, BIO quarterly cash flow from operations has changed by +$60.10M (+86.10%)
What is Bio-Rad Laboratories TTM cash flow from operations?
The current TTM CFO of BIO is $515.30M
What is the all time high TTM CFO for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high TTM cash flow from operations is $792.98M
What is Bio-Rad Laboratories TTM CFO year-on-year change?
Over the past year, BIO TTM cash flow from operations has changed by +$168.72M (+48.68%)